OBIO ▲ +6.4% - Orchestra BioMed Holdings, Inc. $OBIO - Orchestra BioMed Receives $6.1 Million Milestone Payment from Acquisition of Vivasure by Haemonetics Orchestra BioMed rose 6.4% after announcing it received a $6.1 million milestone payment from Haemonetics related to the acquisition of Vivasure. The cash influx from the deal milestone likely boosted investor confidence in the company's financial position and the value of its assets. 15-SEP-2026 08:30 AM ET